相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer
Xiaoying Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Stabilization of MORC2 by estrogen and antiestrogens through GPER1-PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells
Fan Yang et al.
AUTOPHAGY (2020)
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer
Hong-Yi Liu et al.
NUCLEIC ACIDS RESEARCH (2020)
De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism
Maria J. Guillen Sacoto et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents
XiaoHui Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
MORC2 regulates DNA damage response through a PARP1-dependent pathway
Lin Zhang et al.
NUCLEIC ACIDS RESEARCH (2019)
Coumarin-Based Fluorescent Probes for Super-resolution and Dynamic Tracking of Lipid Droplets
Hongkang Xu et al.
ANALYTICAL CHEMISTRY (2019)
MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1
Jiao Liu et al.
CANCER SCIENCE (2019)
Dimerization of MORC2 through its C-terminal coiled-coil domain enhances chromatin dynamics and promotes DNA repair
Hong-Yan Xie et al.
CELL COMMUNICATION AND SIGNALING (2019)
Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations
Paula Sancho et al.
HUMAN MOLECULAR GENETICS (2019)
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators
Nian Liu et al.
NATURE (2018)
Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells
Tao Wang et al.
CELL DEATH AND DIFFERENTIATION (2018)
Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition
Jia-Hong Chen et al.
EXPERIMENTAL CELL RESEARCH (2018)
MUC16 as a novel target for cancer therapy
Abhijit Aithal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Aberrant high expression level of MORC2 is a common character in multiple cancer
Qian-shan Ding et al.
HUMAN PATHOLOGY (2018)
The coming of age of chaperone-mediated autophagy
Susmita Kaushik et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms
Christopher H. Douse et al.
NATURE COMMUNICATIONS (2018)
Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer
Fang-Lin Zhang et al.
CANCER RESEARCH (2018)
Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2
Iva A. Tchasovnikarova et al.
NATURE GENETICS (2017)
The HSP90 chaperone machinery
Florian H. Schopf et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1
Xiao-Hong Liao et al.
ONCOTARGET (2017)
Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease
Teresa Sevilla et al.
BRAIN (2016)
Clinico-genetics in Korean Charcot-Marie-Tooth disease type 2Z with MORC2 mutations
Young Se Hyun et al.
BRAIN (2016)
Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors
Jing Qi et al.
CANCER RESEARCH (2016)
Building better monoclonal antibody-based therapeutics
George J. Weiner
NATURE REVIEWS CANCER (2015)
Alternative approaches to Hsp90 modulation for the treatment of cancer
Jessica A. Hall et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Mechanisms and Functions of ATP-Dependent Chromatin-Remodeling Enzymes
Geeta J. Narlikar et al.
CELL (2013)
The MORC family New epigenetic regulators of transcription and DNA damage response
Da-Qiang Li et al.
EPIGENETICS (2013)
Inhibition of HSP90 molecular chaperones: moving into the clinic
Rocio Garcia-Carbonero et al.
LANCET ONCOLOGY (2013)
Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
Mikko Taipale et al.
CELL (2012)
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression
Ramona Schulz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
MORC2 Signaling Integrates Phosphorylation-Dependent, ATPase-Coupled Chromatin Remodeling during the DNA Damage Response
Da-Qiang Li et al.
CELL REPORTS (2012)
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
Kyung-Hun Lee et al.
CANCER SCIENCE (2011)
HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
Shanu Modi et al.
CLINICAL CANCER RESEARCH (2011)
Determinants and dynamics of genome accessibility
Oliver Bell et al.
NATURE REVIEWS GENETICS (2011)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Mikko Taipale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis
Suruchi Mittal et al.
MOLECULAR CANCER (2009)
Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket
Alison Donnelly et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I Dose-Escalation study
Shanu Modi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IκB kinase (IKK)
Guoliang Qing et al.
CELL RESEARCH (2006)
Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol
Kevin D. Corbett et al.
NUCLEIC ACIDS RESEARCH (2006)
Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors
LH Jensen et al.
CANCER RESEARCH (2005)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function
AD Basso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
GHKL, an emergent ATPase/kinase superfamily
R Dutta et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
分享论文
